Dataset opportunity
Epflex — 监管记录数据集机会
Epflex 持有的中等监管记录数据集，可用于监管 RAG 和合规助手。
Score
69.9
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
许可
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球医疗保健监管事务中的人工智能市场 = 2024 年为 12 亿美元，复合年增长率为 16.7%。
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- ✨Signal
专注于研发工程领域的以数据为驱动的分析
source ↗
Profile
Dataset profile
Type
监管记录数据集
Modality
文本
Sector
医疗保健
Volume
中等
Freshness
定期
Rarity
中等
Accessibility
部分
Legal
公司所有 — 许可权待明确
Buyer persona
RegTech 和合规 AI 供应商
Epflex 持有全面的监管记录数据集，数据类型为文本，包含技术和临床文档、监管申报以及医疗器械合规所需知识库。这些结构化和非结构化数据涵盖了数十年的监管历史，非常适合开发高精度的监管 RAG 模型，以应对复杂的国际标准和申报流程。
全球医疗保健监管事务中的人工智能市场是一个快速增长的领域，2024 年市场价值为12 亿美元，预计复合年增长率为 16.7%。尽管由于MDR/ISO 13485 的限制、涉及专有工艺的高度敏感商业秘密以及需要直接参与的家族式结构而存在访问复杂性，但该数据集的稀有性和直接适用性提供了显著的竞争优势，证明了其战略性解锁价值的努力是值得的。⚠ 尽职调查（有价值的数据，可协商的访问权限）：医疗监管限制（MDR/ISO 13485）适用于技术和临床文档；镍钛合金和 ePTFE 的专有制造工艺是高度敏感的商业秘密；家族式德国中小企业结构可能需要与 Uihlein 家族管理层建立高信任度的直接联系。· 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Epflex 拥有复杂医疗器械的监管文档和知识产权的专有数据集。这些数据是 RegTech 和合规 AI 供应商用于构建和训练复杂的监管 RAG 模型的主要资产。在年增长率超过 16% 的医疗保健监管 AI 市场中，该数据集通过提供真实、实际的合规和专利文本（这些文本并非公开可用），提供了独特的优势。
See dimension details ↓- Dataset Specificity78
主导的“监管”，医疗保健行业，2 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity46
专有领域数据（开放性降低稀有度）
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness62
API/开放（当前）
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
适用于监管 RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand85
高买家需求源于对管理医疗保健行业日益增长的监管复杂性的 AI 驱动解决方案的迫切需求，该市场以 16.7% 的复合年增长率增长。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility56
开放/API 访问
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility66
中等难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 种证据类型，4 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License70
所有权=公司所有，许可=权利不明确
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 个数据需求信号（1 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ 良好目标 — Epflex 是理想目标：一家家族式德国中小企业，是医疗导丝和组件的领先 OEM 制造商，作为其核心业务的副产品，生成了有价值的生产和监管数据。
- Deep Qualification80
✓ 通过 — Epflex 是一个强有力的候选者。作为医疗器械的 OEM 制造商，它本质上会产生指定的“监管记录数据集”，作为其核心业务的副产品。数据归公司所有，商业模式与机会完美契合。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Downloads / exports
该公司提供了一个专用的文档下载门户，表明其拥有分发技术规格和其他有价值的专有文件以进行 B2B 数据采集的结构化流程。
Industrial data
该文本证实该公司从产品测试和材料科学分析中生成数据，提供了支持和验证其监管申报的经验性、数据驱动的证据。
Regulatory records
Epflex 明确创建并管理符合关键国际医疗器械法规（包括ISO 13485 和欧洲MDR）的文档，使其成为真实合规数据的高价值来源。
Knowledge base / docs
持有者拥有大量的知识产权，拥有特定医疗器械的专利，为模型训练提供了独特且专有的高度技术性和法律文本语料库。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Epflex Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global AI in healthcare regulatory affairs market = $1.2B in 2024, CAGR 16.7% (source: Transparency Market Research).. Investment score 69.9/100 (confidence 0.56). Recommended action: License.
From the marketplace
Explore live data opportunities
Valaratomics — 法规记录数据集机会
View opportunity →出行Mt Logistik — 法规记录数据集机会
View opportunity →工业Ecotecworld — 法规记录数据集机会
View opportunity →